Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price traded down 0.6% during trading on Tuesday after Citigroup lowered their price target on the stock from $30.00 to $29.00. Citigroup currently has ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

Dividend stocks can be a great way to boost your portfolio's growth potential or provide a form of passive income over the ...

Some stocks pay juicy dividends for a while only for the income to later dwindle. Others generate consistent and reliable ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

A copy-paste message authentically lists side effects of the Pfizer BioNTech COVID-19 vaccine released by the pharmaceutical company. Rating: Context: The long list of purported "vaccine side effects" ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the migraine drug Nurtec ...